Clinical trials: Infantile Canavan Disease
Canavan Disease, Infantile
Lithium and Acetate for Canavan Disease
The aim of this study is to determine whether oral supplementation with lithium and acetate may improve the biological and clinical prognosis in patients with Canavan Disease.
- Conditions
- Canavan Disease, Infantile, Deficiency Disease, Aspartoacylase
- Trial name
- NCT00657748
- Testing
- Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Infantile Canavan Disease, Deficiency Disease, Aspartoacylase
GTA-Glyceryltriacetate for Canavan Disease
The purpose of this study is to determine whether oral supplementation of glyceryl triacetate improves the clinical prognosis of Canavan Disease.
- Trial name
- NCT00278707
- Testing
- GTA: Glyceryltriacetate
- Where
- Israel
- Volunteers
- 5 people
- Sponsor
- Sheba Medical Center